NMDA receptor modulators and prodrugs, salts, and uses thereof
US9745342B2 · kind B2 · utility
6Cited by
0References
13Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 27, 2014 |
| Grant date | Aug 29, 2017 |
| Priority date | — |
| Expiry date | Oct 27, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compounds having enhanced potency in the modulation of NMD A receptor activity. Such compounds are contemplated for use in the treatment of diseases and disorders, such as learning, cognitive activities, and analgesia, particularly in alleviating and/or reducing neuropathic pain. Orally available formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.